Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Anyone kept track of the day for 90-day preliminary results?

<< Previous

Bullboard Posts

Next >>

Post by gojotv!on Oct 22, 2021 11:52am

397 Views

Post# 34037705

Anyone kept track of the day for 90-day preliminary results?

Will we achieve "Breakthrough designation" this fall, or will we need a few more patients to make the rolls?
The low share price means that success will cause a much-needed pop! Hope it's in time for the Holidays!
GLTA!

<< Previous

Bullboard Posts

Next >>

FE Battery Metals begins 2024 winter drill program